ACAT2 is a target for treatment of coronary heart disease associated with hypercholesterolemia

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 25, Issue 6, 2005, Pages 1112-1118

  Rudel, Lawrence L ^a   Lee, Richard G ^a   Parini, Paolo ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Atherosclerosis; Cholesterol absorption; Cholesteryl ester; Hepatocytes; Lipoproteins

Indexed keywords

CHOLESTEROL; CHOLESTEROL ACYLTRANSFERASE; CHOLESTEROL ACYLTRANSFERASE 1; CHOLESTEROL ACYLTRANSFERASE 2; CHOLESTEROL ESTER; LIPOPROTEIN; STEROL; UNCLASSIFIED DRUG;

APOPTOSIS; ATHEROSCLEROSIS; CELL FUNCTION; CELL MEMBRANE; CELL SURVIVAL; CELL TYPE; CHOLESTEROL ESTERIFICATION; DISEASE ASSOCIATION; GENE DELETION; HYPERCHOLESTEROLEMIA; INTESTINE CELL; ISCHEMIC HEART DISEASE; LIVER CELL; MACROPHAGE; PRIORITY JOURNAL; SHORT SURVEY;

ANIMALS; CORONARY DISEASE; ENZYME INHIBITORS; HUMANS; HYPERCHOLESTEROLEMIA; STEROL O-ACYLTRANSFERASE;

EID: 20144365248     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000166548.65753.1e     Document Type: Short Survey

References (51)

1. Willner EL, Tow B, Buhman KK, Wilson M, Sanan DA, Rudel LL, Farese RV Jr. Deficiency of acyl CoA:cholesterol acyltransferase 2 prevents atherosclerosis in apolipoprotein E-deficient mice. Proc Natl Acad Sci U S A. 2003;100:1262-1267.
2. Lee RG, Kelley KL, Sawyer JK, Farese RV Jr, Parks JS, Rudel LL. Plasma cholesterol esters provided by lecithin:cholesterol acyltransferase and acyl-coenzyme A:cholesterol acyltransferase 2 have opposite atherosclerotic potential. Cir Res. 2004;95:998-1004.
3. Meiner VL, Cases S, Myers HM, Sande ER, Bellosta S, Schambelan M, Pitas RE, McGuire J, Herz J, Farese RV Jr. Disruption of the acyl-CoA:cholesterol acyltransferase gene in mice: Evidence suggesting multiple cholesterol esterification enzymes in mammals. Proc Natl Acad Sci U S A. 1996;93:14041-14046.
4. Accad M, Smith SJ, Newland DL, Sanan DA, King LEJ, Linton MF, Fazio S, Farese RV Jr. Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA:cholesterol acyltransferase I. J Clin Invest. 2000;105:711-719.
5. Yagyu H, Kitamine T, Osuga J, Tozawa R, Chen Z, Kaju Y, Oka T, Perrey S, Tamura Y, Ohashi K, Okazaki H, Yahagi N, Shionoiri F, Iizuka Y, Harada K, Shimano H, Yamashita H, Gotoda T, Yamada N, Ishibashi S. Absence of ACAT-1 attenuates atherosclerosis but causes dry eye and cutaneous xanthomatosis in mice with congenital hyperlipidemia. J Biol Chem. 2000;275:21324-21330.
6. Warner GJ, Stoudt G, Bamberger M, Johnson WJ, Rothblat GH. Cell toxicity induced by inhibition of acyl coenzyme A:cholesterol acyltransferase and accumulation of unesterified cholesterol. J Biol Chem. 1995; 270:5772-5778.
7. Fazio S, Major AS, Swift LL, Cleaves LA, Accad M, Linton MF, Farese RV Jr. Increased atherosclerosis in LDL receptor-null mice lacking ACAT1 in macrophages. J Clin Invest. 2001;107:163-171.
8. Rong JX, Kusunoki J, Oelkers P, Sturley SL, Fisher EA. Acyl-coenzyme A (CoA): Cholesterol acyltransferase inhibition in rat and human aortic smooth muscle cells is nontoxic and retards foam cell formation. Arterioscler Thromb Vasc Biol. 2005;25:122-127.
9. Fazio S, Dove DE, Linton MF. ACAT inhibition. Bad for macrophages, good for smooth muscle cells? Arterioscler Thromb Vasc Biol. 2005; 25:7-9.
10. Lee RG, Willingham MC, Davis MA, Skinner KA, Rudel LL. Differential expression of ACAT1 and ACAT2 among cells within liver, intestine, kidney, and adrenal of nonhuman primates. J Lipid Res. 2000;41: 1991-2001.
11. Joyce CW, Shelness GS, Davis MA, Lee RG, Skinner K, Anderson RA, Rudel LL. ACAT1 and ACAT 2 membrane topology segregates a serine residue essential for activity to opposite sides of the endoplasmic reticulum membrane. Mol Biol Cell. 2000;11:3675-3687.
12. Lin S, Lu X, Chang CCY, Chang T-Y. Human acyl-coenzyme A:cholesterol acyltransferase expressed in Chinese hamster ovary cells: membrane topology and active site location. Mol Biol Cell. 2003;14:2447-2460.
13. Lin S, Cheng D, Liu MS, Chen J, Chang TY. Human Acyl-CoA:Cholesterol acyltransferase-1 in the endoplasmic reticulum contains seven transmembrane domains. J Biol Chem. 1999;274:23276-23285.
14. Lada AT, Davis M, Kent C, Chapman J, Tomoda H, Omura S, Rudel LL. Identification of ACAT1- and ACAT2- specific inhibitors using a novel, cell-based fluorescent assay: individual ACAT uniqueness. J Lipid Res. 2004;45:378-386.
15. Anderson RA, Joyce C, Davis M, Reagan JW, Clark M, Shelness G, Rudel LL. Identification of a form of acyl-CoA:cholesterol acyltransferase specific to liver and intestine in nonhuman primates. J Biol Chem. 1998;273:26747-26754.
16. Cases S, Novak S, Zheng Y-W, Myers HM, Lear SR, Sande E, Welch CB, Lusis AJ, Spencer TA, Krause BR, Erickson SK, Farese RV Jr. ACAT-2, A second mammalian acyl-CoA:cholesterol acyltransferase. Its cloning, expression, and characterization. J Biol Chem. 1998;273: 26755-26764.
17. Oelkers P, Behari A, Cromley D, Billheimer JT, Sturley SL. Characterization of two human genes encoding acyl coenzyme A:cholesterol acyltransferase-related enzymes. J Biol Chem. 1998;273:26765-26771.
18. Chang CCY, Sakashita N, Ornvold K, Lee O, Chang ET, Dong R, Lin S, Lee C-YG. Strom S, Kashyap R, Fung J, Farese RVJ, Patoiseau J-F, Delhon A. Chang TY. Immunological quantitation and localization of ACAT-1 and ACAT-2 in human liver and small intestine. J Biol Chem. 2000;275:28083-28092.
19. Sakashita N, Miyazaki A, Chang CCY, Chang TY, Kiyota E, Satoh M, Komohara Y, Morganelli PM, Horiuchi S, Takeya M. Acyl-coenzyme A:cholesterol acyltransferase 2 (ACAT2) is induced in monocyte-derived macrophages: In vivo and in vitro studies. Lab Invest. 2003;83: 1569-1581.
20. Chang T-Y, Chang CCY, Lin S, Yu C, Li B-L, Miyazaki A. Roles of acyl-coenzyme A: cholesterol acyltransferase-1 and 2. Curr Opin Lipidol. 2001;12:289-296.
21. Parini P, Davis M, Lada AT, Erickson SK, Wright TL, Gustafsson U, Sahlin S, Einarsson C, Eriksson M, Angelin B, Tomoda H, Omura S, Willingham MC, Rudel LL. ACAT2 is localized to hepatocytes and is the major cholesterol esterifying enzyme in human liver. Circulation. 2004; 110:2017-2023.
22. Rudel LL, Haines J, Sawyer JK, Shah R, Wilson MS, Carr TP. Hepatic origin of cholesteryl oleate in coronary artery atherosclerosis in African green monkeys. Enrichment by dietary monounsaturated fat. J Clin Invest. 1997;100:74-83.
23. Rudel LL, Parks JS, Hedrick L, Thomas M, Williford K. Lipoprotein and cholesterol metabolism in diet-induced coronary artery atherosclerosis in primates. Role of cholesterol and fatty acids. Prog Lipid Res. 1998;37: 353-370.
24. Tall AR, Small DM, Atkinson D, Rudel LL. Studies on the structure of low density lipoproteins isolated from Macaca fascicularis fed an atherogenic diet. J Clin Invest. 1978;62:1354-1363.
25. Lee RG, Shah R, Sawyer JK, Hamilton RL, Park JS, Rudel LL. ACAT2 contributes cholesteryl esters to newly secreted VLDL while LCAT adds CE to LDL in mice. J Lipid Res. In press.
26. Dreon DM, Fernstrom HA, Campos H, Blanche P, Williams PT, Krauss RM. Change in dietary saturated fat intake is correlated with change in mass of large low-density-lipoprotein particles in men. Am J Clin Nutr. 1998;67:828-836.
27. Ballesteros MN, Cabrera RM, Saucedo MS, Fernandez ML. Dietary cholesterol does not increase biomarkers for chronic disease in a pediatric population from northern Mexico. Am J Clin Nutr. 2004;80:855-861.
28. Campos H, Roederer GO, Lussier-Cacan S, Davignon J, Krauss RM. Predominance of large LDL and reduced HDL2 cholesterol in normolipidemic men with coronary artery disease. Arterioscler Thromb Vasc Biol. 1995;15:1043-1048.
29. Sherrard B, Simpson H, Cameron J, Wahi S, Jennings G, Dart A. LDL particle size in subjects with previously unsuspected coronary heart disease: Relationship with other cardiovascular risk markers. Atherosclerosis. 1996;126:277-287.
30. Hulthe J, Wiklund O, Bondjers G, Wikstrand J. LDL particle size in relation to intima-media thickness and plaque occurrence int he carotid and femoral arteries in patients with hypercholesterolaemia. J Intern Med. 2000;248:42-52.
31. Campos H, Moye LA, Classer SP, Stampfer MJ, Sacks FM. Low-density lipoprotein size, pravastatin treatment, and coronary events, events. JAMA. 2001;286:1468-1474.
32. Schrade W, Boehle E, Frankfurt MD, Biegler R. Humoral changes in arteriosclerosis. Investigations of lipids, fatty acids, ketone bodies, pyruvic acid, lactic acid, and glucose in the blood. Lancet. 1960;ii: 1409-1416.
33. Lawrie TDV, McAlpine SG, Rifkind BM, Robinson JF. Serum fatty-acid patterns in coronary-artery disease. Lancet. 1961;i:421-424.
34. Kirkeby K, Ingvaldsen P, Bjerkedal I. Fatty acid composition of serum lipids in men with myocardial infarction. Acta Med Scand. 1972;192: 513-519.
35. Kingsbury KJ, Brett C, Stovold R, Chapman A, Anderson J, Morgan DM. Abnormal fatty acid composition and human atherosclerosis. Postgrad Med J. 1974;50:425-440.
36. Klein RL, Rudel LL. Effect of dietary cholesterol level on the composition of thoracic duct lymph lipoproteins isolated from nonhuman primates. J Lipid Res. 1983;24:357-367.
37. Dawson PA, Rudel LL. Intestinal cholesterol absorption. Curr Opin Lipidol. 1999;10:315-320.
38. Rudel LL, Morris MD, Felts JM. The transport of exogenous cholesterol in the rabbit. I. Role of cholesterol ester of lymph chylomicron and lymph very low density lipoproteins in absorption. J Clin Invest. 1972;51: 2686-2692.
39. Repa JJ, Buhman KK, Farese RB Jr, Dietschy JM, Turley SD. ACAT2 deficiency limits cholesterol absorption in the cholesterol-fed mouse: impact on hepatic cholesteol hemeostasis. Hepatology. 2004;40: 1088-1097.
40. Buhman KK, Accad M, Novak S, Choi RS, Wong JS, Hamilton RL, Turley S, Farese RV Jr. Resistance to diet-induced hypercholesterolemia and gallstone formation in ACAT2-deficient mice. Nature Med. 2000;6: 1341-1347.
41. Lee RG. The role of ACAT2 in cholesterol metabolism and atherosclerosis. PhD Thesis. Wake Forest University. Winston-Salem, NC; 2004.
42. Iqbal J, Anwar K, Hussain MM. Multiple, independently regulated pathways of cholesterol transport across the intestinal epithelial cells. J Biol Chem. 2003;278:31610-31620.
43. Cadigan KM, Heider JG, Chang T-Y. Isolation and characterization of Chinese hamster ovary cell mutants deficient in acyl-coenzyme A:cholesterol acyltransferase activity. J Biol Chem. 1988;263:274-282.
44. Spady DK, Willard MN, Meidell RS. Role of acyl-coenzyme A:cholesterol acyltransferase-1 in the control of hepatic VLDL secretion and LDL receptor expression in the mouse and hamster. J Biol Chem. 2000;275: 27005-27012.
45. Davis HR Jr, Zhu L. Hoos LM, Tetzloff G, Maguire M, Liu J, Yao X, Iyler SPN, Lam M-H, Lund EG, Detmers PA, Graziano MP, Altmann SW. Niemann-Pick C1 Like 1 (NPCIL1) is the intestinal phytosterol and cholesterol transporter and a key modulator of whole-body cholesterol homeostasis. J Biol Chem. 2004;279:33586-33592.
46. Temel RE, Gebre AK, Parks JS, Rudel LL. Compared with acyl-CoA:cholesterol O-acyltransferase (ACAT) I and lecithin:cholesterol acyltransferase, ACAT2 displays the greatest capacity to differentiate cholesterol from sitosterol. J Biol Chem. 2003;278:47594-47601.
47. Kellner-Weibel G, Jerome WG, Small DM, Warner GJ, Stoltenborg JK, Kearney MA, Corjay MH, Phillips MC, Rothblat GH. Effects of intracellular free cholesterol accumulation on macrophage viability - A model for foam cell death. Arterioscler Thromb Vasc Biol. 1998;18:423-431.
48. Tabas I. Free cholesterol-induced cytotoxicity - A possible contributing factor to macrophage foam cell necrosis in advanced atherosclerotic lesions. Trends Cardiovasc Med. 1997;7:256-263.
49. Dove DE, Su YR, Zhang W, Jerome WG, Swift LL, Linton MF, Fazio S. ACAT1 deficiency disrupts cholesterol efflux and alters cellular morphology in macrophgaes. Arterioscler Thromb Vasc Biol. 2005;25: 128-134.
50. Yang H, Bard M, Bruner DA, Gleeson A, Deckelbaum RJ, Aljinovic G, Pohl TM, Rothstein R, Sturley SL. Sterol esterification in yeast: a two-gene process. Science. 1996;272:1353-1356.
51. Rudel LL, Davis M, Sawyer J, Shah R, Wallace J. Primates highly responsive to dietary cholesterol upregulate hepatic ACAT2 while less responsive primates do not. J Biol Chem. 2002;277:31401-31406.